← The Wire
ZSQRNasdaq
Z Squared Inc.
Finance Services · DE · CIK 1759186
Coeptis Therapeutics develops cell therapies for diseases and uses AI and RPA for operational enhancement
red 8-K · 90d
$562M
Market cap
$11.67
Last close
-6.3%
1D
-20.7%
5D
671K
Volume
Price · last 39 sessions-17.1%
May 4L $8.16 · H $16.73Jun 29
138
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateJun 29, 2026S-1FORM S-1Jun 26, 20268-KMaterial Agreement · Reg FD DisclosureJun 26, 2026S-1FORM S-1Jun 9, 20268-KMaterial Agreement · Equity IssuanceJun 4, 20268-K/ACompany UpdateJun 1, 20268-KExecutive ChangeMay 22, 20268-KReg FD DisclosureMay 21, 202610-QFORM 10-Q FOR MAR 2026May 15, 2026SC 13D/ASC 13D/AMay 15, 2026SC 13DSC 13DMay 4, 20268-KExecutive Change · Material AgreementMay 1, 20268-KChange of Control · Executive ChangeApr 30, 20268-KCompany UpdateApr 28, 20268-KReg FD DisclosureApr 24, 20268-KCompany UpdateApr 8, 202610-KFORM 10-K FOR DEC 2025Mar 19, 20268-KExecutive Change · Company UpdateFeb 12, 20268-KShareholder VoteFeb 4, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSJan 29, 20268-KDelisting NoticeJan 16, 202610-QFORM 10-Q FOR SEP 2025Nov 14, 202510-QFORM 10-Q FOR JUNE 2025Aug 14, 2025S-4REGISTRATION STATEMENTJun 26, 202510-K/AAMENDMENT NO. 1 TO FORM 10-KJun 3, 202510-QFORM 10-Q FOR MARCH 2025May 14, 20258-KMaterial Agreement · Reg FD DisclosureApr 28, 2025424B4424B3Apr 23, 2025S-1/AAMENDMENT #2 TO FORM S-1Apr 4, 202510-KFORM 10-K FOR DEC 2024Mar 28, 20258-KExecutive ChangeMar 27, 2025S-1/AAMENDMENT NO. 1 TO FORM S-1Feb 7, 20258-KMaterial Agreement · Equity IssuanceJan 24, 20258-KCompany UpdateJan 22, 2025S-1REGISTRATION STATEMENTJan 10, 20258-KBylaw Amendment · Company UpdateDec 27, 20248-KShareholder VoteDec 20, 20248-KCompany UpdateDec 17, 20248-KCompany UpdateDec 4, 2024DEF 14ADEF 14ANov 14, 202410-QFORM 10-Q FOR SEPT 2024Nov 13, 20248-KMaterial AgreementNov 6, 20248-KAuditor ChangeSep 30, 20248-KDelisting Notice · Company UpdateSep 19, 202410-QFORM 10-Q FOR JUNE 2024Aug 16, 202410-Q/AAMENDMENT NO 1 FOR 3-31-24Aug 16, 202410-K/AAMENDMENT NO. 1 FOR 12-31-23Aug 16, 202410-Q/AAMENDMENT NO. 2 FOR 9-30-23Aug 16, 20248-KRestatementAug 14, 20248-KDelisting NoticeJul 31, 20248-KExecutive Change · Equity IssuanceJun 20, 202410-QFORM 10-Q FOR MARCH 2024May 10, 202410-KFORM 10-K FOR 12-31-23Mar 26, 202410-Q/AAMENDMENT NO. 1Mar 25, 202410-Q/AAMENDMENT NO. 1Mar 25, 202410-Q/AAMENDMENT NO. 1Mar 25, 202410-K/AAMENDMENT NO 1Mar 25, 20248-KRestatementMar 25, 2024SC 13GSC 13GFeb 14, 20248-KDelisting Notice · Company UpdateFeb 1, 20248-KShareholder VoteDec 22, 20238-KReg FD DisclosureDec 5, 2023DEF 14ADEF 14ANov 17, 2023S-1REGISTRATION STATEMENTNov 15, 202310-QQUARTERLY REPORTNov 9, 20238-KMaterial Agreement · Equity IssuanceOct 27, 20238-KEquity IssuanceOct 13, 20238-KDelisting NoticeAug 30, 20238-KMaterial Agreement · Acquisition / DispositionAug 22, 202310-QFORM 10-QAug 11, 20238-KMaterial Agreement · Company UpdateJun 16, 2023424B4424B4Jun 15, 2023S-1/AAMENDMENT NO. 4 TO FORM S-1Jun 13, 20238-KDelisting Notice · Company UpdateJun 9, 2023S-1/AAMENDMENT NO. 3 TO FORM S-1Jun 7, 20238-KReg FD DisclosureJun 6, 2023S-1/AAMENDMENT NO. 2 TO FORM S-1May 31, 20238-KExecutive Change · Company UpdateMay 17, 202310-QQUARTERLY REPORTMay 15, 2023S-1/AS-1 AMENDMENT 1 (PRE-EFFECTIVE)Apr 27, 2023
Similar companies
Comparable business profile · signals at a glance